Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BCC 2021 | Focus of the Oncoplastic Breast Consortium

Walter Weber • 12 Mar 2021
BCC 2021
Breast Cancer

Walter Weber, MD, University Hospital Basel, Basel, Switzerland, discusses the focus of the Oncoplastic Breast Consortium including developing current standards of oncoplastic surgery, ongoing randomized trials such as the OPBC-02 PREPEC study (NCT04293146), and addressing knowledge gaps in the field of oncoplastic surgery. This interview took place during the 17th St. Gallen International Breast Cancer Conference.

More from Walter Weber

Pre-pectoral IBBR and oncologic safety following mastectomy
1:20
Pre-pectoral IBBR and oncologic safety following mastectomy
Walter Weber • 30 May 2026
Results from the PREPEC trial support pre-pectoral positioning for IBBR following mastectomy
0:48
Results from the PREPEC trial support pre-pectoral positioning for IBBR following mastectomy
Walter Weber • 30 May 2026
PREPEC (OPBC-02): pre-pectoral vs sub-pectoral IBBR after mastectomy
0:42
PREPEC (OPBC-02): pre-pectoral vs sub-pectoral IBBR after mastectomy
Walter Weber • 30 May 2026
Evaluating the role of axillary surgery after neoadjuvant chemotherapy
2:12
Evaluating the role of axillary surgery after neoadjuvant chemotherapy
Walter Weber • 13 Mar 2025

Related Videos

Highlights in brain metastasis research at ESMO 2026
1:31
Highlights in brain metastasis research at ESMO 2026
Ariane Steindl • 26 Oct 2026
Intraoperative ultrasound assessment of sentinel nodes in breast cancer
2:14
Intraoperative ultrasound assessment of sentinel nodes in breast cancer
Ludovica Pitoni • 4 Nov 2026
AIUR: surgical glove compression for paclitaxel-induced neuropathy in breast cancer
4:38
AIUR: surgical glove compression for paclitaxel-induced neuropathy in breast cancer
Young-Joon Kang • 25 Oct 2026
How can genomic assays guide treatment in HR+/HER2- breast cancer?
1:26
How can genomic assays guide treatment in HR+/HER2- breast cancer?
Kevin Kalinsky • 25 Oct 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals